Bellerophon Therapeutics, Inc. (BLPH)
USD 0.01
(-36.84%)
USD 0.01
(-36.84%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 65 Thousand | 102 Thousand | 147 Thousand | 348 Thousand | 362 Thousand | 373 Thousand |
| Gross Profit | -65 Thousand | -102 Thousand | -147 Thousand | -348 Thousand | -362 Thousand | -373 Thousand |
| Operating Expenses | 22.38 Million | 20.16 Million | 26.27 Million | 17.47 Million | 27.88 Million | 24.59 Million |
| Selling, General and Administrative Expenses | 6.02 Million | 7.14 Million | 8.38 Million | 6.44 Million | 7.62 Million | 6.74 Million |
| Research and Development Expenses | 16.3 Million | 13.01 Million | 17.89 Million | 11.03 Million | 20.25 Million | 17.85 Million |
| Other Expenses | - | - | - | -674 Thousand | 27.88 Million | 24.59 Million |
| Cost and Expenses | 22.38 Million | 20.16 Million | 26.27 Million | 17.47 Million | 27.88 Million | 24.59 Million |
| Operating Income | -22.38 Million | -20.16 Million | -26.27 Million | -17.47 Million | -27.88 Million | -24.59 Million |
| Interest Expense | 135 Thousand | 5000.00 | 250 Thousand | - | - | - |
| Income Tax Expense | -2.41 Million | -1.8 Million | -2.12 Million | -1.8 Million | -5.43 Million | 29.84 Million |
| Earnings before Tax | -22.24 Million | -19.55 Million | -26.85 Million | -15.06 Million | -2.62 Million | -54.81 Million |
| Net Income | -19.83 Million | -17.75 Million | -24.72 Million | -13.26 Million | 2.81 Million | -54.81 Million |
| Earnings Per Share Basic | -2.08 | -1.87 | -3.17 | -2.95 | 0.65 | -21.11 |
| Earnings Per Share Diluted | -2.08 | -1.87 | -3.17 | -2.95 | 0.65 | -21.11 |
| Weighted Average Shares Outstanding | 9.55 Million | 9.5 Million | 7.79 Million | 4.5 Million | 4.33 Million | 2.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.55 Million | 9.5 Million | 7.79 Million | 4.5 Million | 4.33 Million | 2.59 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -22.18 Million | -20.16 Million | -26.7 Million | -14.72 Million | -2.26 Million | -54.44 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 5.64 Million | - | - | - |
| Cost of Revenue | - | 1000.00 | 1000.00 | 65 Thousand | 4000.00 | - |
| Gross Profit | - | -1000.00 | 5.63 Million | -65 Thousand | -4000.00 | - |
| Operating Expenses | 2.17 Million | 5.25 Million | 4.16 Million | 22.38 Million | 5.08 Million | 5.11 Million |
| Selling, General and Administrative Expenses | 1.62 Million | 2.36 Million | 1.6 Million | - | 1.36 Million | 1.36 Million |
| Research and Development Expenses | 544 Thousand | 2.89 Million | 2.55 Million | - | 3.71 Million | 3.75 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.17 Million | 5.25 Million | 4.16 Million | 22.38 Million | 5.08 Million | 5.11 Million |
| Operating Income | -2.17 Million | -5.25 Million | 1.47 Million | -22.38 Million | -5.08 Million | -5.11 Million |
| Interest Expense | - | - | -1.34 Million | 135 Thousand | 88 Thousand | - |
| Income Tax Expense | -109 Thousand | -121.08 Thousand | -1.27 Million | -2.41 Million | 2.41 Million | - |
| Earnings before Tax | -1.92 Million | -5.13 Million | 1.54 Million | -22.24 Million | -5.01 Million | -5.06 Million |
| Net Income | -1.92 Million | -5.13 Million | 2.82 Million | -19.83 Million | -7.43 Million | -5.06 Million |
| Earnings Per Share Basic | -0.16 | -0.42 | 0.27 | - | -0.78 | -0.53 |
| Earnings Per Share Diluted | -0.16 | -0.42 | 0.27 | - | -0.78 | -0.53 |
| Weighted Average Shares Outstanding | 12.23 Million | 12.23 Million | 10.35 Million | 9.55 Million | 9.55 Million | 9.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.23 Million | 12.23 Million | 10.6 Million | 9.55 Million | 9.55 Million | 9.54 Million |
| Gross Margin | - | - | 1.00 | - | - | - |
| EBIT Margin | - | - | 0.26 | - | - | - |
| Profit Margin | - | - | 0.50 | - | - | - |
| EBITDA | -2.31 Million | -5.25 Million | 1.47 Million | - | -5.08 Million | -5.09 Million |
| Earnings Before Tax Margin | - | - | 0.26 | - | - | - |
5134
RIGS
RTOXF
601929
CEOS
UNIP3